Melanoma Research Alliance – pre-clinical, translational, and early clinical research

August 7, 2020 by


The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, staging, and treatment.


The 2020 – 2021 award cycle, is anticipated to support at least $7.6 million in new funding. Proposals will be accepted for Established Investigator, Academic-Industry Partnership, Young Investigator, and Pilot Awards.

Key Dates:

•    October 21, 2020: Young Investigator Award Eligibility Checklist Due
•    November 4, 2020: Full Proposals Due for all Award Mechanisms

All proposals are due by 5:00 pm Eastern Time. Proposals should be submitted via the proposalCENTRAL online application tool:

URL for more information:

Full descriptions of each award opportunity offered, including all Special Opportunity Awards, as well as eligibility criteria and instructions can be found on the MRA website at


Filed Under: Funding Opportunities